INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Feb 22, 2022 |
EVP & General Mgr, Industrial
Trans History: 359
|
EVP & General Mgr, Industrial | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 40,000 | -- | -- |
| Sep 13, 2021 |
Director
Trans History: 111
|
Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 4,250 | -- | -- |
| Aug 27, 2021 |
Director
Trans History: 60
|
Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 15,000 | -- | -- |
| Aug 20, 2021 |
SVP Controller
Trans History: 306
|
SVP Controller | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 13,500 | -- | -- |
| Aug 06, 2021 |
Director, President & CEO
Trans History: 422
|
Director, President & CEO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 160,000 | -- | -- |
| Jun 25, 2021 |
Director
Trans History: 466
|
Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 2,084 | -- | -- |
| Jun 24, 2021 |
Director, President and Chief Scientific
Trans History: 628
|
Director, President and Chief Scientific | Form 4 | Bona fide gift | 211,585 | -- | -- |
| May 19, 2021 |
Director, President & CEO
Trans History: 422
|
Director, President & CEO | Form 4 | Bona fide gift | 41,178 | -- | -- |
| May 14, 2021 |
EVP Research and Development
Trans History: 660
|
EVP Research and Development | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 12,500 | -- | -- |
| Apr 15, 2021 |
Director, President and Chief Scientific
Trans History: 628
|
Director, President and Chief Scientific | Form 4 | Bona fide gift | 14,000 | -- | -- |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.